SYR127063 (BDBM-92454) is a potent and selective inhibitor targeting the HER2 receptor by binding to its reactive conformation. This compound is a valuable research tool for investigating HER2-driven cancers in both cellular and animal models, facilitating studies in oncology and targeted therapy development.
